|
|
TTD Drug ID:
DNC007899
Drug
Information |
Name | 2-aminoquinazoline-4-carboxy-(4-bromophenyl)amide | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C15H11BrN4O/c16-9-5-7-10(8-6-9)18-14(21)13-11-3-1-2-4-12(11)19 -15(17)20-13/h1-8H,(H,18,21)(H2,17,19,20) | InChIKey | DYTZVUGMYADHJM-UHFFFAOYSA-N | Canonical SMILES | C1=CC=C2C(=C1)C(=NC(=N2)N)C(=O)NC3=CC=C(C=C3)Br | Target | Adenosine A3 receptor |  | Inhibitor | [1] | Ref 1 | J Med Chem. 2007 Dec 27;50(26):6596-606. Epub 2007 Nov 30.Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach: from triazoloquinoxaline to a pyrimidine skeleton as a key study. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|